BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
81 results:

  • 1. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The application of
    Dębiec K; Wydmański J; d'Amico A; Gorczewska I; Krzywon A; Cortez AJ; Pelak MJ
    Hell J Nucl Med; 2021; 24(1):66-74. PubMed ID: 33866341
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
    Guo Y; He Y
    Sci Rep; 2020 Oct; 10(1):18352. PubMed ID: 33110097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
    Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
    Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical Efficacy of mFOLFOX6 for Advanced gastric cancer].
    Funasaka C; Kanemasa Y; Shimoyama T; Cho H; Omuro Y
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):49-53. PubMed ID: 32381862
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.
    Rawicz-Pruszyński K; Mielko J; Ciseł B; Skórzewska M; Pikuła A; Gęca K; Skoczylas T; Kubiatowski T; Kurylcio A; Polkowski WP
    Eur J Surg Oncol; 2019 Oct; 45(10):1957-1963. PubMed ID: 31178298
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
    Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
    Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
    Choi IS; Kim JH; Lee JH; Suh KJ; Lee JY; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
    PLoS One; 2018; 13(10):e0205853. PubMed ID: 30346970
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice.
    Lv Y; Song L; Chang L; Zhang X; Liu Y; Liu W
    J Cancer Res Ther; 2018; 14(Supplement):S190-S196. PubMed ID: 29578172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trial.
    Chen J; Xiong J; Wang J; Zheng L; Gao Y; Guan Z
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e310-e316. PubMed ID: 29372626
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.
    Settas N; Faucz FR; Stratakis CA
    Mol Cell Endocrinol; 2018 Jul; 469():107-111. PubMed ID: 28739378
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
    Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
    World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [A Case of Recurrent Esophagogastric Junction cancer Responding to Trastuzumab].
    Kobayashi Y; Hirao M; Yamamoto K; Nishikawa K; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Ikeda M; Nakamori S; Sekimoto M; Mori K; Mano M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2181-2183. PubMed ID: 28133262
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bevacizumab followed by chemotherapy is potential therapy for gastric cancer.
    Lv Y; Song L; Chang L; Liu Y; Zhang X; Wang Y; Wang L; Liu W
    J BUON; 2016; 21(6):1466-1470. PubMed ID: 28039709
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibitory effects of bevacizumab monoclonal antibodies in combination with chemotherapy in different time sequences on a human gastric carcinoma cell line.
    Lv Y; Song L; Chang L; Liu Y; Zhang X; Li Q; Zhou X; Liu W
    Ir J Med Sci; 2017 May; 186(2):275-280. PubMed ID: 27351431
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.
    Huang H; Han Y; Zhang C; Wu J; Feng J; Qu L; Shou C
    Tumour Biol; 2016 Mar; 37(3):3527-34. PubMed ID: 26453116
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases.
    Ben Nasr S; Ayadi M; Bahloul R; Guesmi S; Allani B; Chrait N; Rifi H; Rais H; Mezlini A
    Tunis Med; 2015 Apr; 93(4):228-30. PubMed ID: 26375739
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer.
    Osumi H; Yoshio T; Chin K; Ogura M; Kumekawa Y; Suenaga M; Matsusaka S; Shinozaki E; Miyamoto Y; Morishige K; Ishiyama A; Hirasawa T; Tsuchida T; Yamamoto Y; Fujisaki J; Igarashi M; Mizunuma N
    Gastric Cancer; 2016 Apr; 19(2):625-630. PubMed ID: 26260873
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A long-term survivor of cT4 esophageal carcinoma treated via a multimodal approach - a case report].
    Ikai A; Fujiwara H; Shiozaki A; Konishi H; Kosuga T; Komatsu S; Ichikawa D; Okamoto K; Morimura R; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2016-8. PubMed ID: 25731407
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.